Skip to content
buyWeak

Mudit K. Jain bought $2,785 of CVRX

director at CVRx, Inc.. 600 shares at an average of $4.64, traded Feb 18, 2026, filed Feb 18, 2026.

Conviction score
36
Value
$2,785
600 shares
Holdings after
5,650
+12% from before
From 52-week low
+2%
low $4.74, close $4.85
From 52-week high
-68%
high $14.98, as of Feb 18, 2026

Score components

  • Role
    Director
    +15
  • Trade size
    $3k at market
    0
  • Relative to holdings
    Holdings up 12%
    +3
  • Price context
    2% above the 52-week low; 68% below the 52-week high
    +18
  • Cluster
    No other insider buying within 14 days
    0
  • Repeat buying
    First buy in 90 days
    0
  • Track record
    Too few past buys to judge (0 with prices)
    0

What happened after comparable buys

Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.

This signal so far: 1m +79.2%, 3m +24.9%, 6m -41.9%.

Price around the trade, and since

From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.

CVRXOct 12, 2026 · close 1.48
Since filing Feb 18, 2026: -69.5%SPY +14.3% · excess -83.7%

Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™

Rows in this filing

Every transaction in Form 4 0001584404-26-000002, as filed. Open on EDGAR

DateTransactionSharesPriceValueHoldings afterFiled
Feb 18, 2026POpen-market purchase
Common Stock
+600$4.64$2,7855,650Feb 18, 2026

Related signals

Other insiders at CVRx, Inc. and this insider’s other filings.

ScoreCompanyInsiderValueHoldingsFiled
0Weak
CVRXsell10b5-1
CVRx, Inc.
Brent Binkowski
CHIEF OPERATING OFFICER
$3,338
1,309 shares
-4%
46Moderate
CVRXbuy
CVRx, Inc.
Brent Binkowski
CHIEF OPERATING OFFICER
$76k
26,223 shares
+87%
10Weak
CVRXsell 510b5-1
CVRx, Inc.
Philip B. Adamson
Chief Medical Officer
$9,973
1,262 shares
-2%
27Weak
CVRXsell 510b5-1
CVRx, Inc.
Kevin Hykes
PRES & CEO
$61k
7,763 shares
-3%
17Weak
CVRXsell 510b5-1
CVRx, Inc.
Jared Oasheim
CHIEF FINANCIAL OFFICER
$14k
1,744 shares
-2%
10Weak
CVRXsell 510b5-1
CVRx, Inc.
Paul Verrastro
CHIEF MKTG & STRAT OFFICER
$10k
1,284 shares
-2%
15Weak
CVRXsell 510b5-1
CVRx, Inc.
Robert Allen John
Chief Revenue Officer
$31k
3,964 shares
-4%
45Moderate
CVRXbuy
CVRx, Inc.
Mudit K. Jain
director
$298k
46,800 shares
+5%
24Weak
CVRXsell
CVRx, Inc.
Johnson & Johnson
owner
$224k
22,337 shares
-1%
20Weak
CVRXsell
CVRx, Inc.
Johnson & Johnson
owner
$64k
6,337 shares
-0%

Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.

Mudit K. Jain bought $2,785 of CVRX | InsiderTell